• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. 40MM OXINIUM MODULAR HEAD; PROSTHESIS, HIP, SEMI-CONSTRAINED, UNCEMENTED, METAL/POLYMER, POROUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. 40MM OXINIUM MODULAR HEAD; PROSTHESIS, HIP, SEMI-CONSTRAINED, UNCEMENTED, METAL/POLYMER, POROUS Back to Search Results
Catalog Number 71342340
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Post Operative Wound Infection (2446)
Event Date 12/12/2023
Event Type  Injury  
Manufacturer Narrative
H10.Initial reference number:(b)(4).
 
Event Description
It was reported that, after a primary thr performed on (b)(6) 2023, the patient presented with a suspected infection of the hip replacement.They required to come back to theatre for a wound and joint wash out and head exchange.Patient's outcome is unknown.
 
Manufacturer Narrative
The devices were not returned for evaluation; therefore, a device analysis could not be performed.The clinical/medical investigation concluded that the provided x-rays were reviewed but do not aid in determining a clinical root cause of the reported infection, as the infection cannot be viewed on the images.However, the one of the undated x-ray images does appear to show a void in the femoral cortex around the stem which could indicate fracture or a remaining void from a previous procedure (such as cerclage cable or cortical screw).The reported infection is highly likely of an exogenous nature, and it cannot be concluded the reported infection was associated with the implant.The patient impact is the reported infection and subsequent incision and drainage and revision.A review of the production orders did not reveal a manufacturing abnormality that could have caused or contributed to the reported incident.A review of complaint history for the part number over the past 12 months and for the batch number based on historical data of the device did not reveal similar events for the listed device.A review of the risk management files revealed this failure mode was previously identified.The anticipated risk level is still adequate.A historical review concluded that there are no prior actions related to this products and event.A review of the instructions for use documents for total hip systems revealed infection, both early, post-operative superficial and early, post-operative deep wound infection and late periprosthetic infection has been identified in potential complications associated with total hip arthroplasty surgery, primary or revision section.A review of the sterilization records revealed the batches were sterilized within normal parameters.At this time, we have no evidence to conclude that the products failed to meet any specifications at the time of manufacture.Factors that could contribute to the reported event include loss of sterility during procedure, post-operative healing issue, injury, patient condition and/or medical history.Based on this investigation, the need for corrective action is not indicated.Should the devices or additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
 
Event Description
It was reported that, after a primary thr performed on (b)(6) 2023, a revision had to be carried out on (b)(6) 2023 due to infection of the hip replacement.The infection included the deep tissues and debridement and washout of all layers was performed.The primary femoral head and taper sleeve were explanted.Further debridement of tissue within the hip joint and around the femoral stem was also undertaken.Patient's current health status is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
40MM OXINIUM MODULAR HEAD
Type of Device
PROSTHESIS, HIP, SEMI-CONSTRAINED, UNCEMENTED, METAL/POLYMER, POROUS
Manufacturer (Section D)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer (Section G)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key18436496
MDR Text Key331835611
Report Number1020279-2024-00010
Device Sequence Number1
Product Code MBL
UDI-Device Identifier00885556112410
UDI-Public00885556112410
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K093363
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/03/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue Number71342340
Device Lot Number16KM02664
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/04/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured10/05/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
71344245 / LOT NUMBER: 18AT98135.
Patient Outcome(s) Required Intervention; Hospitalization;
-
-